GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 420 filers reported holding GUARDANT HEALTH INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,070,000 | +143.2% | 112,756 | +82.3% | 0.01% | +200.0% |
| Q2 2022 | $2,496,000 | +38.1% | 61,866 | +126.8% | 0.00% | +100.0% |
| Q1 2022 | $1,807,000 | -80.0% | 27,274 | -69.8% | 0.00% | -71.4% |
| Q4 2021 | $9,040,000 | +183.5% | 90,380 | +254.3% | 0.01% | +133.3% |
| Q3 2021 | $3,189,000 | -25.6% | 25,511 | -26.1% | 0.00% | -40.0% |
| Q2 2021 | $4,287,000 | -67.2% | 34,521 | -59.6% | 0.01% | -73.7% |
| Q1 2021 | $13,058,000 | +953.1% | 85,545 | +789.0% | 0.02% | +850.0% |
| Q4 2020 | $1,240,000 | -68.6% | 9,623 | -72.8% | 0.00% | -83.3% |
| Q3 2020 | $3,948,000 | -7.0% | 35,317 | -32.5% | 0.01% | -40.0% |
| Q2 2020 | $4,243,000 | +75.0% | 52,298 | +50.1% | 0.02% | 0.0% |
| Q1 2020 | $2,425,000 | +19.4% | 34,843 | +34.1% | 0.02% | +42.9% |
| Q4 2019 | $2,031,000 | +94.5% | 25,992 | +59.0% | 0.01% | +75.0% |
| Q3 2019 | $1,044,000 | +884.9% | 16,349 | +1235.7% | 0.01% | +700.0% |
| Q2 2019 | $106,000 | – | 1,224 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |